SCHEMBL2570702

SCHEMBL2570702

CCOC(=O)Oc1nc(N)cn1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SOAT1 P35610 1/20 0.35
CA2 P00918 1/20 0.35
CYP1A2 P05177 3/20 0.35
LMNA P02545 3/20 0.35
LPO P22079 2/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4062335 0.78 MITF (0.50) ALDH1A1HPGDHTTMEN1KMT2A
SCHEMBL2567237 0.76 LMNA (0.39) LMNA
SCHEMBL1594748 0.75 ADORA3 (0.46) ADORA3ADORA2AADORA1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL1852651 0.74 ALDH1A1 (0.45) ADORA3ADORA2AADORA1ALDH1A1KDM4E
SCHEMBL10975927 0.71 ALDH1A1 (0.38) ADORA3ADORA2AADORA1ALDH1A1KDM4E
SCHEMBL4664835 0.70 ADORA2A (0.44) ADORA3ADORA2AADORA1ALDH1A1KDM4E
SCHEMBL1758561 0.70 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL10508790 0.69 BAZ2B (0.41) ADORA3ADORA2AADORA1ALDH1A1KDM4E
SCHEMBL23283973 0.68 MAPK1 (0.44) ALDH1A1MEN1KMT2ANPC1MAPT
SCHEMBL8284977 0.66 MAPK1 (0.34) ADORA3ADORA2AADORA1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2755964-B1 SULFONIC ACID SALTS OF HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS ANTI INFECTIVE CURES GMBH (DE) 2016-06-22 EP disclosed
EP-1732901-B1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND AICURIS GMBH & CO KG (DE) 2011-11-02 EP disclosed
EP-1853582-B1 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS GMBH & CO KG (DE) 2009-10-21 EP disclosed
EP-1853582-A2 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AiCuris GmbH & Co. KG (DE) 2007-11-14 EP disclosed
EP-1732901-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND Bayer HealthCare AG (DE) 2006-12-20 EP disclosed
WO-2006089664-A2 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS GMBH & CO. KG (DE) 2006-08-31 WO disclosed
WO-2005092865-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND BAYER HEALTHCARE AG (DE) 2005-10-06 WO disclosed